CEMEC - Centro Multidisciplinar de Estudos Clínicos LTDA-EPP

São Bernardo do Campo, São Paulo 09715-090

0 studies enrolling now · 2 studies all time

What they study most

Coronavirus Disease 2019 (COVID-19) Pneumonia, Idiopathic Pulmonary Fibrosis

Studies at this site

• Zephyrus II: Efficacy and Safety Study of Pamrevlumab in Participants With Idiopathic Pulmonary Fibrosis (IPF) — Stopped early
• Phase 3 Study to Evaluate Efficacy and Safety of Lenzilumab in Patients With COVID-19 — Status unconfirmed